Neurotoxicity and Neuroprotection

Neurotoxicity and Neuroprotection

September 2009 – Vol 11 – No. 3

State of the art

Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression
Ronald S. Duman, PhD

Translational research

Chromatin regulation in drug addiction and depression
William Renthal, PhD; Eric J. Nestler, MD, PhD

Neuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia
David A. Lewis, MD

The role of astroglia in neuroprotection
Mireille Bélanger, PhD; Pierre J. Magistretti, MD; PhD

Estradiol: a hormone with diverse and contradictory neuroprotective actions
Phyllis M. Wise, PhD; Shotaro Suzuki, PhD; Candice M. Brown, PhD

Neurotoxicity of drugs of abuse – the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines
Euphrosyne Gouzoulis-Mayfrank, MD; Joerg Daumann, PhD

Pharmacological aspects

The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders – relation to drug treatment
Norbert Müller, MD, PhD, DipPsych

The neurotrophic and neuroprotective effects of psychotropic agents
Joshua Hunsberger, PhD

Brief report

Neuroplasticity in addictive disorders
Charles P. O’Brien, MD, PhD